These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 17470673)

  • 1. Does cardiac resynchronization therapy reduce sudden cardiac deaths?
    Lam SK; Owen A
    Eur Heart J; 2007 May; 28(10):1268; author reply 1268-9. PubMed ID: 17470673
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antitachycardia and resynchronization devices in the treatment of heart failure and prevention of sudden death].
    Sapel'nikov OV; Latypov RS; Grishin IR; Mareev IuV; Saidova MA; Akchurin RS
    Kardiologiia; 2011; 51(9):60-7. PubMed ID: 21943010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiac resynchronization therapy-always with ICD?].
    Stellbrink C
    Herz; 2005 Nov; 30(7):596-600. PubMed ID: 16333584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors and the effect of cardiac resynchronization therapy on cardiac and non-cardiac mortality in MADIT-CRT.
    Perkiomaki JS; Ruwald AC; Kutyifa V; Ruwald MH; Mcnitt S; Polonsky B; Goldstein RE; Haigney MC; Krone RJ; Zareba W; Moss AJ;
    Europace; 2015 Dec; 17(12):1816-22. PubMed ID: 26071234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saving lives and reducing inappropriate device therapy: the MADIT family of implantable cardioverter-defibrillator and cardiac resynchronization therapy trials.
    Moss AJ
    Cardiol J; 2013; 20(3):217-9. PubMed ID: 23788293
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cardiac resynchronization therapy in chronic heart failure].
    Sticherling C
    Praxis (Bern 1994); 2007 Mar; 96(11):421-2. PubMed ID: 17405535
    [No Abstract]   [Full Text] [Related]  

  • 8. [Electrical treatment in heart failure].
    Leclercq C; Mabo P; Daubert C
    Rev Prat; 2010 Sep; 60(7):947-50. PubMed ID: 21033492
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of sudden death in heart failure patients: cardiac resynchronization therapy with or without defibrillation back-up].
    Pedretti RF; Laporta A; Masnaghetti S; Raimondo R; Salerno M; Santoro F; Vaninetti R
    G Ital Cardiol (Rome); 2010 Oct; 11(10 Suppl 1):134S-136S. PubMed ID: 21416844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardiac defibrillators and cardiac resynchronization therapy for heart failure in older adults.
    Goldfinger JZ; Choi AD; Adler ED
    Geriatrics; 2009 Aug; 64(8):20-9. PubMed ID: 20722313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias.
    Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH
    Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of implantable cardiac defibrillators in heart failure are confirmed.
    Tanne JH
    BMJ; 2004 Mar; 328(7441):664. PubMed ID: 15031233
    [No Abstract]   [Full Text] [Related]  

  • 13. The evolution and revolution of the implantable cardioverter defibrillator.
    Indik JH
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):461-4. PubMed ID: 15225105
    [No Abstract]   [Full Text] [Related]  

  • 14. Implantable defibrillators with and without resynchronization for patients with left ventricular dysfunction.
    Narayan SM
    Tex Heart Inst J; 2005; 32(3):358-61. PubMed ID: 16392218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable cardioverter-defibrillators in children.
    Blom NA
    Pacing Clin Electrophysiol; 2008 Feb; 31 Suppl 1():S32-4. PubMed ID: 18226032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Implantable cardioverters-defibrillators: prevention of sudden death].
    Bokeriia LA; Revishvili ASh; Neminushiĭ NM
    Kardiologiia; 2009; 49(2):84-9. PubMed ID: 19254226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why the Authors Use Cardiac Resynchronization Therapy with Defibrillators.
    Sze E; Daubert JP
    Card Electrophysiol Clin; 2015 Dec; 7(4):695-707. PubMed ID: 26596812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiarrhythmic therapy for the prevention of sudden cardiac death.
    Cairns J; Kerr C; Teo K
    Can J Cardiol; 2000 Jun; 16 Suppl C():29C-33C. PubMed ID: 10887276
    [No Abstract]   [Full Text] [Related]  

  • 19. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials.
    Kusumoto FM; Calkins H; Boehmer J; Buxton AE; Chung MK; Gold MR; Hohnloser SH; Indik J; Lee R; Mehra MR; Menon V; Page RL; Shen WK; Slotwiner DJ; Stevenson LW; Varosy PD; Welikovitch L
    Circulation; 2014 Jul; 130(1):94-125. PubMed ID: 24815500
    [No Abstract]   [Full Text] [Related]  

  • 20. [The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death should not restrict their use].
    Francia P; Cappato R
    G Ital Cardiol (Rome); 2011 May; 12(5):379-82; discussion 382. PubMed ID: 21593958
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.